Looking ahead, mAb 99D may provide a unique probe of Bin1 function in AD, perhaps with the opportunity to illuminate how gut-brain connections might be leveraged to prevent, arrest or reverse AD pathology, especially with regard to potential contributions of neuro-inflammation as a disease modifier as well as phosphorylated tau as a disease driver. This evidence concerns the gene MAPT and Alzheimer disease.